Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) Meeting Abstract
| Authors: | Omuro, A. M. P.; Beal, K.; McNeill, K. A.; Thomas, A. A.; Lin, X.; Kaley, T. J.; DeAngelis, L. M.; Mellinghoff, I. K.; Diamond, E. L.; Chan, T. A. T.; Young, R. J.; Yamada, Y.; Gorman, G.; Lamson, M.; Bavisotto, L. M.; Karmali, R. A. |
| Abstract Title: | Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 107s |
| Language: | English |
| ACCESSION: | WOS:000404665403047 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.2060 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2060 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
